Business Description
Welgene Biotech Co Ltd
ISIN : TW0006661002
Share Class Description:
ROCO:6661: Ordinary SharesDescription
Welgene Biotech Co Ltd is engaged in providing clinical testing service. It service and products offerings include next-generation sequencing service, microarray service, OPS diagnostics products, and Biovesicle products. The company also offers clinical testing agents and instruments.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.47 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 4.58 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.54 | |||||
| Beneish M-Score | -3.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14.3 | |||||
| 3-Year EBITDA Growth Rate | -24.7 | |||||
| 3-Year Book Growth Rate | 0.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.39 | |||||
| 9-Day RSI | 41.36 | |||||
| 14-Day RSI | 43.11 | |||||
| 6-1 Month Momentum % | -8.32 | |||||
| 12-1 Month Momentum % | 6.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.63 | |||||
| Quick Ratio | 2.25 | |||||
| Cash Ratio | 1.79 | |||||
| Days Inventory | 100.38 | |||||
| Days Sales Outstanding | 53.16 | |||||
| Days Payable | 28.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -48.7 | |||||
| 3-Year Average Share Buyback Ratio | -4 | |||||
| Shareholder Yield % | -9.44 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.36 | |||||
| Operating Margin % | -0.67 | |||||
| Net Margin % | -0.42 | |||||
| FCF Margin % | 10.24 | |||||
| ROE % | -0.45 | |||||
| ROA % | -0.25 | |||||
| ROIC % | -0.67 | |||||
| ROC (Joel Greenblatt) % | 0.46 | |||||
| ROCE % | 0.25 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 19.23 | |||||
| Price-to-Owner-Earnings | 23.35 | |||||
| PS Ratio | 1.81 | |||||
| PB Ratio | 1.87 | |||||
| Price-to-Tangible-Book | 1.86 | |||||
| Price-to-Free-Cash-Flow | 16.44 | |||||
| Price-to-Operating-Cash-Flow | 13.39 | |||||
| EV-to-EBIT | 482.96 | |||||
| EV-to-EBITDA | 16.06 | |||||
| EV-to-Revenue | 1.56 | |||||
| EV-to-FCF | 14.96 | |||||
| Price-to-Projected-FCF | 1.69 | |||||
| Price-to-Net-Current-Asset-Value | 7.28 | |||||
| Earnings Yield (Greenblatt) % | 0.2 | |||||
| FCF Yield % | 5.86 | |||||
| Forward Rate of Return (Yacktman) % | -8.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Welgene Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 308.55 | ||
| EPS (TTM) (NT$) | -0.044 | ||
| Beta | 0.48 | ||
| Volatility % | 31.49 | ||
| 14-Day RSI | 43.11 | ||
| 14-Day ATR (NT$) | 0.604853 | ||
| 20-Day SMA (NT$) | 23.725 | ||
| 12-1 Month Momentum % | 6.13 | ||
| 52-Week Range (NT$) | 22 - 39.4 | ||
| Shares Outstanding (Mil) | 23.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Welgene Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Welgene Biotech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Welgene Biotech Co Ltd Frequently Asked Questions
What is Welgene Biotech Co Ltd(ROCO:6661)'s stock price today?
The current price of ROCO:6661 is NT$23.15. The 52 week high of ROCO:6661 is NT$39.40 and 52 week low is NT$22.00.
When is next earnings date of Welgene Biotech Co Ltd(ROCO:6661)?
The next earnings date of Welgene Biotech Co Ltd(ROCO:6661) is .
Does Welgene Biotech Co Ltd(ROCO:6661) pay dividends? If so, how much?
Welgene Biotech Co Ltd(ROCO:6661) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers